GB942452A - Unsaturated fatty acids and salts thereof and a process for their preparation - Google Patents

Unsaturated fatty acids and salts thereof and a process for their preparation

Info

Publication number
GB942452A
GB942452A GB4203659A GB4203659A GB942452A GB 942452 A GB942452 A GB 942452A GB 4203659 A GB4203659 A GB 4203659A GB 4203659 A GB4203659 A GB 4203659A GB 942452 A GB942452 A GB 942452A
Authority
GB
United Kingdom
Prior art keywords
general formula
compound
reacting
metal
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4203659A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB4203659A priority Critical patent/GB942452A/en
Publication of GB942452A publication Critical patent/GB942452A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/18Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon triple bonds as unsaturation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention comprises compounds of the general formula: CH3(CH2)x-CH2-C­C-(CH2)7-COOR (wherein x is 1, 3, 5 or 7 and R represents hydrogen or one equivalent of another physiologically harmless cation, e.g. a physiologically harmless metal such as an alkali metal, calcium, magnesium or aluminium, ammonium or the cation of an organic base, e.g. an ethanolamine, ethylene-diamine, procaine, piperidine, pyrrolidine, morpholine, streptomycin, dihydrostreptomycin or isonicotinic acid hydrazide), and the preparation thereof by (a) condensing a compound of the general formula: CH3-(CH2)x1-C­C-R1 (wherein x1 is 2, 4, 6 or 8 and R1 represents a metal or a Grignard reagent residue) with a compound of the general formula: Hal-(CH2)7-R2 (wherein Hal represents a halogen atom and R2 represents -COOR or a radical convertible thereto), or (b) reacting a compound of the general formula: R1-C­-C(CH2)7-R2 with a compound of the general formula: Hal-CH2-(CH2)x-CH3, or (c) eliminating a substituent capable of elimination from the heptamethylene chain of a compound of the general formula: CH3(CH2)x-CH2-C­C-(CH2) 7-R2 (if necessary after protection of the triple bond), and in all cases, if necessary, converting R2 to -COOR, and, if desired, converting a resulting acid into a salt with a physiologically harmless base or a resulting salt into the free acid. Pharmaceutical preparations.-The foregoing compounds have inflammation- and edemainhibiting activity, for which purpose they may be injected, e.g. intravenously or intraninsularly, in the form of physiological isotonic solutions of the appropriate salts, or suspensions of sparingly soluble salts or of the free acids. 1-Chlorohexadecyne-(8) is prepared by reacting nonyne- (1) with 1-chloro-7-iodoheptane in the presence of sodamide or lithium amide, or by reacting 9-chlorononyne-(1) with heptyl iodide in the presence of lithium amide. Analogous compounds are obtained by replacing nonyne-(1) by pentyne-(1), heptyne-(1) or undecyne-(1) in the first process. 9-Chlorononyne-(1) is prepared by reacting 1-chloro-7-iodoheptane with sodium acetylide. Organometallic compounds of the second general formula above are prepared by reacting pentyne-(1), heptyne-(1), nonyne-(1) or undecyne-(1), or their mercury compounds, in a boiling inert solvent, with the salt-forming metal or metal compound added in finely divided form, e.g. finely divided lithium, magnesium, lithium amide, sodium oxide, ethyl magnesium bromide or phenyl lithium.
GB4203659A 1959-12-10 1959-12-10 Unsaturated fatty acids and salts thereof and a process for their preparation Expired GB942452A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB4203659A GB942452A (en) 1959-12-10 1959-12-10 Unsaturated fatty acids and salts thereof and a process for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4203659A GB942452A (en) 1959-12-10 1959-12-10 Unsaturated fatty acids and salts thereof and a process for their preparation

Publications (1)

Publication Number Publication Date
GB942452A true GB942452A (en) 1963-11-20

Family

ID=10422533

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4203659A Expired GB942452A (en) 1959-12-10 1959-12-10 Unsaturated fatty acids and salts thereof and a process for their preparation

Country Status (1)

Country Link
GB (1) GB942452A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2235449A (en) * 1989-08-24 1991-03-06 Univ Southampton Dinuclear complexes and methods of preparing optical fibres therefrom
WO2011092467A1 (en) * 2010-01-27 2011-08-04 Equateq Limited Process for preparing and purifying fatty acids

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2235449A (en) * 1989-08-24 1991-03-06 Univ Southampton Dinuclear complexes and methods of preparing optical fibres therefrom
WO2011092467A1 (en) * 2010-01-27 2011-08-04 Equateq Limited Process for preparing and purifying fatty acids
CN102844289A (en) * 2010-01-27 2012-12-26 巴斯夫制药(卡兰尼什)公司 Process for preparing and purifying fatty acids
AU2011209584B2 (en) * 2010-01-27 2014-02-06 Basf Pharma (Callanish) Limited Process for preparing and purifying fatty acids
RU2553473C2 (en) * 2010-01-27 2015-06-20 Басф Фарма (Калланиш) Лимитед Method for producing and purifying fatty acids
US9079847B2 (en) 2010-01-27 2015-07-14 Basf Pharma (Callanish) Limited Process for preparing and purifying fatty acids
CN102844289B (en) * 2010-01-27 2016-01-20 巴斯夫制药(卡兰尼什)公司 For the preparation of the method with purification of fatty acid

Similar Documents

Publication Publication Date Title
GB842804A (en) Preparation of substituted piperazines
GB942452A (en) Unsaturated fatty acids and salts thereof and a process for their preparation
ES391633A1 (en) 2,2,-diaryl-4-4-aryl-4-hydroxy-piperidino butyramides
GB1043510A (en) D-(--)-n-alkyl-1-phenyl-2-aminoethanols
GB1378446A (en) Process for the manufacture of dicyanovinyl compounds
ES454280A1 (en) 1-(2-(' naphthyloxy)ethyl)-3-methylpyrazolone-(5) and antithrombotic and antithrombolytic compositions and methods utilizing them
ES329009A1 (en) A procedure for the preparation of compounds of general formula t-y-co-r. (Machine-translation by Google Translate, not legally binding)
US2329883A (en) Mercuri-acetylide compound and method of preparing the same
ES441434A1 (en) /harmaceutical compositions containing 2-naphthyl-butyric acid derivatives
ES435351A1 (en) 1-(3-phenylpropyl)-4-furoylpiperazine derivatives
GB746051A (en) S:s-diethyldithioterephthalate and therapeutic compositions containing the same
GB985486A (en) Phenylisopropylamine derivatives and process for preparing them
ES454348A1 (en) Prosta-4,13-dienoic acid derivatives
GB1060069A (en) Improvements in or relating to phenylethanolamines
GB1489702A (en) Therapeutically active dioxamic acid derivatives
GB1412663A (en) 2- 4-biphenylyl- tetrahydrofurans and pharmaceutical compositions containing them
ES433843A1 (en) Substituted 4,4-dicyclohexylmethane derivatives and microbicidal preparations containing them
ES400623A1 (en) Pharmaceutical compositions
GB1001827A (en) Araliphatic amines, a process for their manufacture and pharmaceutical preparations containing them
ES447917A1 (en) Process for the synthesis of prostaglandins
GB1058403A (en) Improvements in or relating to novel 4-aza-thiaxanthene derivatives
ES339128A1 (en) Azabicycloalkane derivatives
GB1006385A (en) Isopropanols and the manufacture thereof
ES386397A1 (en) Substituted phenylacetonitriles
GB969025A (en) Dihydrodibenzocycloheptene derivatives